ProfileGDS5822 / ILMN_1255126
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 31% 35% 30% 34% 0% 17% 37% 4% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.731
GSM1276600PDAC Late Ablation Control 218.835
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 113.530
GSM1276603PDAC Late Ablation 216.434
GSM1276604PDAC Late Ablation 30.10
GSM1303940PDAC Late Ablation_anti-CTLA4 111.917
GSM1303941PDAC Late Ablation_anti-CTLA4 217.737
GSM1303942PDAC Late Ablation_anti-CTLA4 33.14